CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Mexico

Publisher Name:
Published Date: 1-Jul-2014
No. of pages: 279

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Mexico”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Mexico. It identifies the key trends in the country’s healthcare market and provides insights into its healthcare infrastructure and demographic, regulatory and reimbursement landscape. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The population of Mexico was approximately 118.8 million in 2013, and is estimated to grow at a Compound Annual Growth Rate (CAGR) of 1.8%, to approximately 128.6 million in 2020. This is due to a positive balance between the birth and mortality rates. The government has been successful in implementing the steps necessary for achieving universal healthcare coverage, such as reforms in the System of Social Protection in Health (Sistema de Protección Social en Salud). The value of the Mexican pharmaceutical market amounted to $14 billion, in 2013, and is expected to increase at a CAGR of 7% to reach approximately $22.5 billion in 2020. The medical device market was worth $3.6 billion in 2013 and is projected to reach $5.4 billion in 2020, at a CAGR of 6.1%. These positive growth trends can be attributed primarily to government initiatives in the public healthcare sector and an improved and updated regulatory environment.

Scope

The report provides information on the healthcare, regulatory and reimbursement landscape in Mexico, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market and medical devices market. The key players covered for the pharmaceutical market are Pfizer, Sanofi, Merck, Novartis and Genomma Lab Internacional. The key players covered for the medical devices market are Fresenius Medical Care, F. Hoffmann-La Roche, DePuy Companies, Siemens Healthcare and Medtronic.
  • Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges facing growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving Mexico’s healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Mexico’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and being informed of the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnership
  • Identify, understand and capitalize on the opportunities and challenges in Mexico’s healthcare market

Table of Contents For This Report

Table of Contents

1 Table of Contents 6

1.1 List of Tables 10

1.2 List of Figures 14

2 Introduction 19

2.1 GlobalData Report Guidance 19

3 Overview of the Pharmaceutical and Medical Device Markets 20

3.1 Pharmaceutical Market 20

3.1.1 Market Overview 20

3.1.2 Pharmaceutical Exports and Imports 23

3.1.3 Supply Channels 24

3.1.4 Market Segments 24

3.1.5 Major Disease Areas 26

3.1.6 Major Players 28

3.2 Medical Device Market 66

3.2.1 Market Overview 66

3.2.2 Overview of Top Five Segments 68

3.2.3 Diagnostics Market 82

3.2.4 Major Players 85

3.3 Market Drivers and Barriers 118

3.3.1 Drivers 118

3.3.2 Barriers 119

4 Market Access 121

4.1 Reimbursement and Payer Landscape 121

4.1.1 Overview of Healthcare system 121

4.1.2 Reimbursement Process 123

4.1.3 Overview of Insurance Providers 127

4.1.4 Patient Share in Healthcare Spending 129

4.1.5 Price Trends in the Healthcare Sector 130

4.1.6 Pricing Policies 132

4.2 Regulatory Landscape 133

4.2.1 Overview of Regulatory Agencies 133

4.2.2 Market Authorization Procedure for Pharmaceutical Products 134

4.2.3 New Medical Device Approval Process 137

4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 139

4.2.5 Exports and Imports 141

4.2.6 Intellectual Property Rights 143

4.2.7 Clinical Trial Regulations 147

4.2.8 Pharmaceutical Advertising Regulations 149

4.2.9 Pharmacy Regulations 152

4.2.10 Labeling and Packaging Regulations 153

5 Country Analysis 155

5.1 Political Environment 155

5.1.1 Political Structure 155

5.1.2 Analysis of the Current Political Environment 157

5.1.3 Healthcare Policy Initiatives 160

5.2 Economic Landscape 162

5.3 Economic Indicators 169

5.3.1 Gross Domestic Product 169

5.3.2 Gross National Income 173

5.3.3 Inflation 175

5.3.4 Currency Exchange Rate 178

5.3.5 Foreign Direct Investment 179

5.3.6 Foreign Exchange Reserves 180

5.3.7 Trade Balance 182

5.3.8 General Government Structural Balance 185

5.3.9 General Government Net Debt 186

5.3.10 Major Industries 189

5.4 Demographics 190

5.4.1 Population 190

5.4.2 Education and Literacy 210

5.4.3 Employment 211

5.4.4 Disease Burden 213

5.5 Healthcare Infrastructure 217

5.5.1 Healthcare Facilities 217

5.5.2 Healthcare Parameters 230

5.5.3 Environmental Health 232

5.5.4 Healthcare Personnel 240

5.6 Healthcare Expenditure 243

5.6.1 Overview 243

5.6.2 Major Components of Healthcare Spending 245

5.6.3 Public and Private Sector Share 246

5.6.4 Spending in Healthcare R&D 247

5.7 Trade Associations 248

5.7.1 Mexican Association of Pharmaceutical Research 248

5.7.2 National Association of Pharmaceutical Manufacturers 248

5.7.3 Mexican Association of Pharmaceutical Laboratories 249

5.7.4 National Chamber of the Pharmaceutical Industry 249

5.8 Trade Fairs 250

6 Opportunities and Challenges 251

6.1 Opportunities 251

6.2 Challenges 251

7 Appendix 253

7.1 Abbreviations 253

7.2 Bibliography 259

7.3 Research Methodology 276

7.3.1 Coverage 276

7.3.2 Secondary Research 277

7.3.3 Forecasts 277

7.3.4 Expert Panel 278

7.4 Disclaimer 278

List of Tables

Table 1: Pharmaceutical Market, Mexico, Revenue ($bn), 2008-2013 22

Table 2: Pharmaceutical Market, Mexico, Revenue Forecast ($bn), 2014-2020 22

Table 3: Pharmaceutical Market, Mexico, Exports and Imports ($bn), 2008-2013 24

Table 4: Pharmaceutical Market, Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 34

Table 5: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2014 35

Table 6: Pharmaceutical Market , Merck, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 42

Table 7: Pharmaceutical Market , Merck, Global, Late-Stage Pipeline, 2014 43

Table 8: Pharmaceutical Market, Sanofi, Global, Major Products, Revenue ($bn), 2013 50

Table 9: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2014 51

Table 10: Pharmaceutical Market, Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 56

Table 11: Pharmaceutical Market, Novartis, Global, Planned Filings, 2014-2018 57

Table 12: Medical Device Market, Mexico, Revenue ($bn), 2008-2013 67

Table 13: Medical Device Market, Mexico, Revenue ($bn), Forecast, 2014-2020 68

Table 14: Medical Device Market, Mexico, Revenue by Segment, 2013 69

Table 15: Medical Device Market, Mexico, Ophthalmic Devices Market ($m), 2008-2013 71

Table 16: Medical Device Market, Mexico, Ophthalmic Devices Market, Sales Trend for Major Players ($m), 2012 72

Table 17: Medical Device Market, Mexico, Nephrology and Urology Devices Market ($m), 2008-2013 73

Table 18: Medical Device Market, Mexico, Nephrology and Urology Devices Market, Sales Trend for Major Players, 2012 74

Table 19: Medical Device Market, Mexico, Orthopedic Device Market ($m), 2008-2013 76

Table 20: Medical Device Market, Mexico, Orthopedic Device Market, Sales Trend for Major Players, 2012 77

Table 21: Medical Device Market, Mexico, In Vitro Diagnostics Device Market ($m), 2008-2013 78

Table 22: Medical Device Market, Mexico, In Vitro Diagnostics Device Market, Sales Trend for Major Players, 2012 79

Table 23: Medical Device Market, Mexico, Diabetes Care Devices Market ($m), 2008-2013 81

Table 24: Medical Device Market, Mexico, Diabetes Care Devices Market, Sales Trend for Major Players, 2012 82

Table 25: Medical Device Market, Mexico, Diagnostics Market, Revenue ($m), 2008-2013 83

Table 26: Medical Device Market, Mexico, Diagnostic Market Revenue Forecast($m), 2014-2020 84

Table 27: Medical Device Market, Mexico, Major Medical Device Companies Revenue, 2012 85

Table 28: Medical Device Market, Fresenius Medical Care, Global, Major Products, 2014 87

Table 29: Medical Device Market , F. Hoffmann-La Roche, Global, Major Products, 2014 93

Table 30: Medical Device Market, Medtronic, Global, Major Products, Revenue ($bn), 2013 111

Table 31: Market Access, Mexico, Out-of-Pocket Expenditure (%), 2008-2013 130

Table 32: Market Access, Price of Healthcare Products, Mexico, Change in Average Price of Healthcare Services (%), 2008-2013 132

Table 33: Market Access, Mexico, Regulatory Fee Structure, Pharmaceutical Products, 2014 137

Table 34: Market Access, Mexico, Medical Device Approval Timelines, 2014 139

Table 35: Market Access, Mexico, Regulatory Fee Structure, Medical Devices, 2014 139

Table 36: Economic Indicators, Mexico, Gross Domestic Product per Capita ($), 2008-2013 170

Table 37: Economic Indicators, Mexico, Gross Domestic Product per Capita Forecast ($), 2014-2020 171

Table 38: Economic Indicators, Mexico, Gross Domestic Product Annual Growth (%), 2008-2013 172

Table 39: Economic Indicators, Mexico, Gross Domestic Product Annual Growth Forecast (%), 2014-2020 173

Table 40: Economic Indicators, Mexico, Gross National Income Per Capita ($), 2008-2013 174

Table 41: Economic Indicators, Mexico, Average Consumer Price Index, 2008-2013 175

Table 42: Economic Indicators, Mexico, Average Consumer Price Index Forecast, 2014-2020 176

Table 43: Economic Indicators, Mexico, Average Consumer Price Annual Change (%), 2008-2013 177

Table 44: Economic Indicators, Mexico Currency Exchange Rate (MXN/$), 2008-2013 178

Table 45: Economic Indicators, Mexico, Foreign Direct Investment ($bn), 2008-2013 180

Table 46: Economic Indicators, Mexico, Foreign Exchange Reserves ($bn), 2008-2013 181

Table 47: Economic Indicators, Mexico, Imports of Goods and Services ($bn), 2008-2013 183

Table 48: Economic Indicators, Mexico, Exports of Goods and Services ($bn), 2008-2013 184

Table 49: Economic Indicators, Mexico, Government Structural Balance ($bn), 2008-2013 186

Table 50: Economic Indicators, Mexico, General Government Net Debt ($bn), 2008-2013 187

Table 51: Economic Indicators, Mexico, General Government Net Debt Forecast ($bn), 2014-2020 188

Table 52: Economic Indicators, Mexico, Major Industries, Share of GDP (%), 2012 190

Table 53: Demographics, Mexico, Population (Million), 2008-2013 191

Table 54: Demographics, Mexico, Population Forecast (Million), 2014-2020 192

Table 55: Demographics, Mexico, Population, Urban and Rural Population Share (%), 2008-2013 193

Table 56: Demographics, Mexico, Population, Urban and Rural Population Share Forecast (%), 2014-2020 194

Table 57: Demographics, Mexico, Population Distribution by Age Group (%), 2008-2013 196

Table 58: Demographics, Mexico, Population Distribution by Age Group Forecast (%), 2014-2020 197

Table 59: Demographics, Mexico, Births (per 1,000 Population), 2008-2013 198

Table 60: Demographics, Mexico, Mortality (per 1,000 Population), 2008-2013 200

Table 61: Demographics, Mexico, Major Causes of Mortality (‘000), 2012 201

Table 62: Demographics, Mexico, Children under Five, Mortality Rate (per 1,000 Live Births), 2008-2013 203

Table 63: Demographics, Mexico, Immunization Rate (%), 2008-2013 204

Table 64: Demographics, Mexico, Major Causes of Male Mortality (‘000), 2012 206

Table 65: Demographics, Mexico, Major Causes of Female Mortality (‘000), 2012 207

Table 66: Demographics, Mexico, Gender Ratio (M/F), 2008-2013 208

Table 67: Demographics, Mexico, Life Expectancy at Birth (Years), 2008-2013 209

Table 68: Demographics, Mexico, Student Enrollment by Level of Education (%), 2011 211

Table 69: Demographics, Mexico, Unemployment Rate (%), 2008-2013 212

Table 70: Demographics, Mexico, Employed Population by Economic Sector (%), 2013 213

Table 71: Demographics, Mexico, Incidence (per 100,000 Population), 2012 215

Table 72: Demographics, Mexico, Major Diseases, DALYs (per 100,000 Population), 2004 216

Table 73: Healthcare Infrastructure, Mexico, Hospitals, 2008-2013 218

Table 74: Healthcare Infrastructure, Mexico, Public and Private Hospitals, 2008-2013 219

Table 75: Healthcare Infrastructure, Mexico, Hospital by Standard of Care (%), 2010 221

Table 76: Healthcare Infrastructure, Mexico, Public Hospitals by Number of Beds, 2008-2013 222

Table 77: Healthcare Infrastructure, Mexico, Public Hospitals without Coverage Plan, 2008-2013 224

Table 78: Healthcare Infrastructure, Mexico, Public Hospitals with Coverage Plan, 2008-2013 226

Table 79: Healthcare Infrastructure, Mexico, Beds (per 1,000 Population) by Type of Service, 2008-2013 227

Table 80: Healthcare Infrastructure, Mexico, Diagnostic Equipment (per 1,000,000 Population), 2008-2013 228

Table 81: Healthcare Infrastructure, Mexico, Diagnostic Centers, 2008-2013 229

Table 82: Healthcare Infrastructure, Mexico, Hospital Beds (per 1,000 Population), 2008-2013 231

Table 83: Healthcare Infrastructure, Mexico, Doctors (per 1,000 Population), 2008-2013 232

Table 84: Healthcare Infrastructure, Mexico, Environmentally Attributable Deaths (per 100,000 Population), 2004 233

Table 85: Healthcare Infrastructure, Mexico, PM10 (µg/m3), 2008-2013 234

Table 86: Healthcare Infrastructure, Mexico, CO2 Emissions (Million Metric Tons), 2008-2013 237

Table 87: Healthcare Infrastructure, Mexico, Population Coverage with Sewerage (%), 2008-2013 238

Table 88: Healthcare Infrastructure, Mexico, Waste Generation (Million Metric Tons), 2008-2013 240

Table 89: Healthcare Infrastructure, Mexico, Nurses (Per 1,000 Population), 2008-2013 241

Table 90: Healthcare Infrastructure, Mexico, Dentists (per 1,000 Population), 2008-2013 242

Table 91: Healthcare Expenditure, Mexico, Healthcare Expenditure (% of GDP), 2008-2013 244

Table 92: Healthcare Expenditure, Mexico, Public Healthcare Expenditure, Share of Major Components (%), 2011 245

Table 93: Healthcare Expenditure, Mexico, Healthcare Expenditure, Public-Private Share (%), 2008-2013 246

Table 94: Healthcare Expenditure, Mexico, Healthcare Research and Development Expenditure ($m), 2008-2013 248

Table 95: Healthcare Expenditure, Mexico, Major Healthcare Trade Fairs, 2014-2015 250

List of Figures

Figure 1: Pharmaceutical Market, Mexico, Revenue ($bn), 2008-2013 21

Figure 2: Pharmaceutical Market, Mexico, Revenue Forecast ($bn), 2014-2020 22

Figure 3: Pharmaceutical Market, Mexico, Exports and Imports ($bn), 2008-2013 23

Figure 4: Medical Device Market, Mexico, Revenue ($bn), 2008-2013 67

Figure 5: Medical Device Market, Mexico, Revenue Forecast ($bn), 2014-2020 68

Figure 6: Medical Device Market, Mexico, Revenue by Segment ($m), 2013 69

Figure 7: Medical Device Market, Mexico, Ophthalmic Devices Market ($m), 2008-2013 70

Figure 8: Medical Device Market, Mexico, Ophthalmic Devices Market, Sales Trend for Major Players ($m), 2008-2012 71

Figure 9: Medical Device Market, Mexico, Nephrology and Urology Devices Market ($m), 2008-2013 73

Figure 10: Medical Device Market, Mexico, Nephrology and Urology Devices Market, Sales Trend for Major Players ($m), 2008-2012 74

Figure 11: Medical Device Market, Mexico, Orthopedic Device Market ($m), 2008-2013 75

Figure 12: Medical Device Market, Mexico, Orthopedic Device Market, Sales Trend for Major Players ($m), 2008-2012 76

Figure 13: Medical Device Market, Mexico, In Vitro Diagnostics Device Market ($m), 2008-2013 78

Figure 14: Medical Device Market, Mexico, In Vitro Diagnostics Device Market, Sales Trend for Major Players ($m), 2008-2012 79

Figure 15: Medical Device Market, Mexico, Diabetes Care Devices Market ($m), 2008-2013 80

Figure 16: Medical Device Market, Mexico, Diabetes Care Devices Market, Sales Trend for Major Players ($m), 2008-2012 81

Figure 17: Medical Device Market, Mexico, Diagnostics Market, Revenue ($m), 2008-2013 83

Figure 18: Medical Device Market, Mexico, Diagnostic Market Revenue Forecast ($m), 2014-2020 84

Figure 19: Medical Device Market, Mexico, Major Medical Device Companies Revenue ($m), 2012 85

Figure 20: Healthcare Market, Mexico, Drivers and Barriers, 2014 120

Figure 21: Market Access, Mexico, Addition of Drug in Basic Formulary, 2014 126

Figure 22: Market Access, Mexico, Out-of-Pocket Expenditure (%), 2008-2013 130

Figure 23: Market Access, Price of Healthcare Products, Mexico, Change in Average Price of Healthcare Services, 2008-2013 131

Figure 24: Market Access, Mexico, Marketing Authorization Procedure, 2014 136

Figure 25: Market Access, Licensing Process for Manufacture of Pharmaceuticals and Medical Devices, Mexico, 2014 140

Figure 26: Market Access, Mexico, Patent Approval Process, 2014 145

Figure 27: Market Access, Mexico, Trademark Approval Process, 2014 147

Figure 28: Market Access, Mexico, Clinical Trial Approval Process, 2014 149

Figure 29: Economic Indicators, Mexico, Gross Domestic Product per Capita ($), 2008-2013 170

Figure 30: Economic Indicators, Mexico, Gross Domestic Product per Capita Forecast ($), 2014-2020 171

Figure 31: Economic Indicators, Mexico, Gross Domestic Product Annual Growth (%), 2008-2013 172

Figure 32: Economic Indicators, Mexico, Gross Domestic Product Annual Growth Forecast (%), 2014-2020 173

Figure 33: Economic Indicators, Mexico, Gross National Income Per Capita ($), 2008-2013 174

Figure 34: Economic Indicators, Mexico, Average Consumer Price Index, 2008-2013 175

Figure 35: Economic Indicators, Mexico, Average Consumer Price Index Forecast, 2014-2020 176

Figure 36: Economic Indicators, Mexico, Average Consumer Price Annual Change (%), 2008-2013 177

Figure 37: Economic Indicators, Mexico, Currency Exchange Rate (MXN/$), 2008-2013 178

Figure 38: Economic Indicators, Mexico, Foreign Direct Investment ($bn), 2008-2013 180

Figure 39: Economic Indicators, Mexico, Foreign Exchange Reserves ($bn), 2008-2013 181

Figure 40: Economic Indicators, Mexico, Imports of Goods and Services ($bn), 2008-2013 182

Figure 41: Economic Indicators, Mexico, Exports of Goods and Services ($bn), 2008-2013 184

Figure 42: Economic Indicators, Mexico, Government Structural Balance ($bn), 2008-2013 185

Figure 43: Economic Indicators, Mexico, General Government Net Debt ($bn), 2008-2013 187

Figure 44: Economic Indicators, Mexico, General Government Net Debt Forecast ($bn), 2014-2020 188

Figure 45: Economic Indicators, Mexico, Major Industries, Share of GDP (%), 2012 189

Figure 46: Demographics, Mexico, Population (Million), 2008-2013 191

Figure 47: Demographics, Mexico, Population Forecast (Million), 2014-2020 192

Figure 48: Demographics, Mexico, Population, Urban and Rural Population Share (%), 2008-2013 193

Figure 49: Demographics, Mexico, Population, Urban and Rural Population Share Forecast (%), 2014-2020 194

Figure 50: Demographics, Mexico, Population Distribution by Age Group (%), 2008-2013 196

Figure 51: Demographics, Mexico, Population Distribution by Age Group Forecast (%), 2014-2020 197

Figure 52: Demographics, Mexico, Births (per 1,000 Population), 2008-2013 198

Figure 53: Demographics, Mexico, Mortality (per 1,000 Population), 2008-2013 199

Figure 54: Demographics, Mexico, Major Causes of Mortality (‘000), 2012 201

Figure 55: Demographics, Mexico, Children under Five, Mortality Rate (per 1,000 Live Births), 2008-2013 203

Figure 56: Demographics, Mexico, Immunization Rate (%), 2008-2013 204

Figure 57: Demographics, Mexico, Major Causes of Male Mortality (‘000), 2012 205

Figure 58: Demographics, Mexico, Major Causes of Female Mortality (‘000), 2012 206

Figure 59: Demographics, Mexico, Gender Ratio (M/F), 2008-2013 208

Figure 60: Demographics, Mexico, Life Expectancy at Birth (Years), 2008-2013 209

Figure 61: Demographics, Mexico, Student Enrollment by Level of Education (%), 2011 211

Figure 62: Demographics, Mexico, Unemployment Rate (%), 2008-2013 212

Figure 63: Demographics, Mexico, Employed Population by Economic Sector (%), 2013 213

Figure 64: Demographics, Mexico, Incidence (per 100,000 Population), 2012 214

Figure 65: Demographics, Mexico, Major Diseases, DALYs (per 100,000 Population), 2004 216

Figure 66: Healthcare Infrastructure, Mexico, Hospitals, 2008-2013 218

Figure 67: Healthcare Infrastructure, Mexico, Public and Private Hospitals, 2008-2013 219

Figure 68: Healthcare Infrastructure, Mexico, Hospital by Standard of Care (%), 2010 220

Figure 69: Healthcare Infrastructure, Mexico, Public Hospitals by Number of Beds, 2008-2013 222

Figure 70: Healthcare Infrastructure, Mexico, Public Hospitals without Coverage Plan, 2008-2013 224

Figure 71: Healthcare Infrastructure, Mexico, Public Hospitals with Coverage Plan, 2008-2013 226

Figure 72: Healthcare Infrastructure, Mexico, Beds (per 1,000 Population) by Type of Service, 2008-2013 227

Figure 73: Healthcare Infrastructure, Mexico, Diagnostic Equipment (per 1,000,000 Population), 2008-2013 228

Figure 74: Healthcare Infrastructure, Mexico, Diagnostic Centers, 2008-2013 229

Figure 75: Healthcare Infrastructure, Mexico, Hospital Beds (per 1,000 Population), 2008-2013 230

Figure 76: Healthcare Infrastructure, Mexico, Doctors (per 1,000 Population), 2008-2013 231

Figure 77: Healthcare Infrastructure, Mexico, Environmentally Attributable Deaths (per 100,000 Population), 2004 232

Figure 78: Healthcare Infrastructure, Mexico, PM10 (µg/m3), 2008-2013 234

Figure 79: Healthcare Infrastructure, Mexico, CO2 Emissions (Million Metric Tons), 2008-2013 236

Figure 80: Healthcare Infrastructure, Mexico, Population Coverage with Sewerage (%), 2008-2013 238

Figure 81: Healthcare Infrastructure, Mexico, Waste Generation (Million Metric Tons), 2008-2013 239

Figure 82: Healthcare Infrastructure, Mexico, Nurses (per 1,000 Population), 2008-2013 241

Figure 83: Healthcare Infrastructure, Mexico, Dentists (per 1,000 Population), 2008-2013 242

Figure 84: Healthcare Expenditure, Mexico, Healthcare Expenditure (% of GDP), 2008-2013 244

Figure 85: Healthcare Expenditure, Mexico, Public Healthcare Expenditure, Share of Major Components (%), 2011 245

Figure 86: Healthcare Expenditure, Mexico, Healthcare Expenditure, Public-Private Share (%), 2008-2013 246

Figure 87: Healthcare Expenditure, Mexico, Healthcare Research and Development Expenditure ($m), 2008-2013 247

Figure 88: Healthcare Market, Mexico, Opportunities and Challenges, 2014 252

Get Updates

Share This Post

Latest Reports from Life Sciences category

© 2014 MarketOptimizer.org. All rights reserved.